Replies to post #75337 on NanoViricides Inc. (NNVC)

[ZincFinger]

The 10 June application for US Dengue orphan drug status started a very strong upward trend that continued unbroken (except for a very brief dip after the secondary from which it returned right back to above the trend line) that continued til NNVC moved to a higher exchange and then it spiked sharply UP (but pulled back to the trend line from that overshoot.) It was then about 5.50

ONLY when the current hostage taking crisis in Washington became extreme did it go below this very powerful trend that lead to a solid doubling of the SP (not even including the spike). The hostage taking resulted in a pullback from the trend line of about 10% to about where it is today.

Discounting the spike to 7.50 (which was far above the trend line) NNVC has held onto it's very rapid recent gains far better than most biotech that had similarly large gains in such a short time period.

This argues strongly IMHO for a resumption of the trend line when (and IF) the hostage taking crisis in DC is resolved IF there are no serious results (damage to credit rating etc.)

The US application for Dengue Orphan drug status took slightly over a month to get approved. The European application was submitted the first week of September so it could be approved at any point now. IMHO there is no reason to doubt that it will be approved. Given that the approval of the US application was apparently the factor causing the upward trend to start I would expect that a European approval would at the least prompt a resumption of the trend line.

So I stand corrected: the NEXT PR is likeliest to be a European approval, given the timing, IMHO.



(Good point! I'd forgotten about the European application for orphan status for Dengue)